Healthcare - Biotechnology - NASDAQ - US
$ 6.17
-5.8 %
$ 524 M
Market Cap
-4.67
P/E
BALANCE SHEET
269 M
ASSETS
13.2 M
LIABILITIES
255 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Terns Pharmaceuticals, Inc.
| Current Assets | 267 M |
| Cash & Short-Term Investments | 263 M |
| Receivables | 0 |
| Other Current Assets | 3.99 M |
| Non-Current Assets | 1.08 M |
| Long-Term Investments | 0 |
| PP&E | 1.03 M |
| Other Non-Current Assets | 56 K |
| Current Liabilities | 11.9 M |
| Accounts Payable | 2.52 M |
| Short-Term Debt | 1.21 M |
| Other Current Liabilities | 8.22 M |
| Non-Current Liabilities | 1.21 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 1.21 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 79.9 | 143.2 | 47.7 | 74.9 | 12.3 | 82.5 |
| Short Term Investments | 183.5 | 139.9 | 118.3 | 0 | 7.3 | 4.4 |
| Receivables | 0 | 0 | 0 | 12.7 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 3.0 | 0 | 0 |
| Other Current Assets | 4.0 | 2.1 | 1.9 | 3.3 | 2.6 | 1.6 |
| Total Current Assets | 267.4 | 285.2 | 166.9 | 90.9 | 22.2 | 88.5 |
| PP&E | 1.0 | 1.8 | 1.0 | 1.2 | 1.0 | 0.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 56 K | 37 K | 94 K | 0.2 | 0.7 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 268.5 | 287.0 | 168.1 | 92.3 | 23.9 | 89.1 |
| LIABILITIES | ||||||
| Accounts Payable | 2.5 | 1.6 | 2.1 | 0.9 | 1.6 | 0.9 |
| Short Term Debt | 1.2 | 1.3 | 0 | 12.9 | 0 | 0 |
| Other Current Liabilities | 7.0 | 4.4 | 3.9 | 7.5 | 3.3 | 1.5 |
| Total Current Liabilities | 11.9 | 8.5 | 6.8 | 22.8 | 5.0 | 2.4 |
| Long Term Debt | 0 | 0.5 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0.8 | 0.7 | 0.3 | 0.1 |
| Other Liabilities | 1.2 | 1.1 | 0.9 | 0.9 | 14.4 | 14.3 |
| Total Liabilities | 13.2 | 10.1 | 7.8 | 23.7 | 19.7 | 16.8 |
| EQUITY | ||||||
| Common Stock | 6 K | 5 K | 3 K | 0 | 0 | 0 |
| Retained Earnings | (332.6) | (242.4) | (182.1) | (131.9) | (91.9) | (23.3) |
| Other Accumulative Comprehensive Income/Loss | 19 K | (0.8) | (0.3) | (0.1) | (0.1) | 59 K |
| Total Equity | 255.4 | 276.9 | 160.3 | 160.9 | 18.3 | 86.6 |
| Total Liabilities and Equity | 268.5 | 287.0 | 168.1 | 92.3 | 23.9 | 89.1 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 71.3 | 36.0 | 25.3 | 25.1 | 25.1 | 24.0 |